ESOMAR-certified consulting firm Future Market Insights (FMI) projects sports nutrition market to register an impressive growth through 2021 & beyond. Demand for organic sports nutrition beverages will increase, augmenting the sales in the market. Newly released Future Market Insights (FMI) analysis projects global demand for sports nutrition market to total US$ 19,302.2 Mn in 2021. As per the report, the overall …
Author Archives: Editor AN
Continuous Glucose Monitoring Systems Market to reach a valuation of ~US$ 3.0 Billion by 2032
[Report of 261 Pages] The market for continuous glucose monitoring systems is anticipated to reach a valuation of US$ 1.1 billion in 2022 and then grow at a CAGR of 10.8% to US$ 3.0 billion by the end of 2032. In 2021, the global continuous glucose monitoring systems market will be dominated by sensors, with a share …
High Content Screening Market is projected to expand at a CAGR of 5.9% over the forecast to 2031
The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of …
Real Time Continuous Microbiological Monitoring Systems Market Growth Forecast To 2030
Pharmaceutical and biotechnology companies who produce medicine and biotech products are concern about airborne microbial contamination. Traditionally, these companies use active air samplers or settling plate method to detect the airborne microbial contamination. But, this method may require at least four to ten days to detect the microbial contamination in the lab. Real time continuous microbiological …
Ocular Drug Delivery Systems sales will total US$ 27.82 Bn by 2031
[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031. Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical …
Continue reading “Ocular Drug Delivery Systems sales will total US$ 27.82 Bn by 2031”
Andersen Tawil Syndrome Treatment Market is projected to reach US$ 4.2 Billion by 2033
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to pharmaceutical companies, increasing awareness among …
Restrictive Cardiomyopathy Treatment Market is expected to garner a market value of US$ 100 Million in 2023
The global restrictive cardiomyopathy treatment market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023-2033. The market for Restrictive Cardiomyopathy Treatment registered a CAGR of 4% in the historical period …
Prinzmetal Angina Therapeutics Market is expected to reach US$ 17.2 Billion by 2033
The global prinzmetal angina therapeutics market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of alcohol and …
Heterozygous Familial Hypercholesterolemia (HEFH) Management Market to reach US$ 58.54 Billion by 2033 | FMI
In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …
PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033
A recently published study by FMI expects the global PCSK9 inhibitors market to augment at a 15.8% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 inhibitors bind to and …
Continue reading “PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033”